Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 204 (abbreviated as RNA5SP204) is a non-functional genomic sequence in humans, classified as a pseudogene derived from the 5S rRNA family. 5S rRNA is a core structural RNA in the large subunit of the ribosome, essential for protein synthesis in all life domains except mitochondria of fungi and animals[1][3]. Pseudogenes like RNA5SP204 arise from ancestral functional genes and share high sequence similarity, but accumulate mutations that prevent normal expression or function[2][4]. rRNA pseudogenes are not transcribed into functional rRNA or proteins and, except for rare cases of antisense or regulatory non-coding roles, are not active in cell biology or disease pathways[2]. There are no known drugs, biomarkers, or reported safety concerns associated with this specific pseudogene. The gene name "RNA, 5S ribosomal pseudogene 204" follows the official style for rRNA pseudogenes in current human genome annotation[4]. This locus is not considered a therapeutic target, receptor, enzyme, transporter, or transcription factor. Its only biological or molecular significance may be as a historical or genomic marker of rRNA gene evolution and duplication events. RNA, 5S ribosomal pseudogene 204 (RNA5SP204) is a non-coding rRNA pseudogene in humans, unrelated to any canonical therapeutic target classes. It has no established biological function or disease association and is not targeted by any drugs[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 204 (RNA5SP204).